文献速递胃肠外科围术期管理与 ERAS

机器人全直肠系膜切除术前拔除尿管联合围术期坦索罗辛的可行性评估

Early removal of urinary catheter before extubation in robotic total mesorectal excision with perioperative tamsulosin.
PubMed 文献 · Surg Endosc · 2026-09-18

本前瞻性单中心服务评估纳入48例接受机器人全直肠系膜切除术的直肠癌患者,在包含围术期坦索罗辛的综合路径下于拔管前即刻拔除尿管。46例(95.8%)成功实现即刻拔管且无需再置管,2例(4.2%)因临床显著尿潴留需临时再置管,均为长期接受药物治疗的良性前列腺增生患者。

要点

  • 机器人TME围术期路径中拔管前即刻拔除尿管可行,95.8%患者无需再置管。
  • 再置管仅见于原有良性前列腺增生并长期药物治疗者,提示需个体化评估。
  • 路径下未观察到尿路感染、吻合口漏、重大并发症、再入院或死亡。

核心结论

  • 在预定义综合围术期路径下,机器人TME拔管前即刻拔除尿管是可行的。
  • 结果支持进一步前瞻性对照评估,但不能解读为优于传统尿管管理的证据。
  • 再置管事件集中于原有良性前列腺增生患者,支持进一步研究个体化术后排尿管理。

研究设计与样本

  • 连续纳入48例接受机器人TME的直肠癌患者,均按预定义综合围术期路径管理。
  • 所有手术使用da Vinci Xi机器人平台;坦索罗辛0.4 mg每日一次,术前3天及术后3天给药。
  • 尿管在拔管前即刻拔除;主要终点为即刻拔管成功且术后无需再置管。

主要发现

  • 平均年龄61岁,男性31例(64.6%)。
  • 46/48例(95.8%)成功实现拔管前即刻拔除尿管且术后无需再置管。
  • 2例(4.2%;精确95%CI 0.5-14.3%)因临床显著术后尿潴留需临时再置管,均为长期接受药物治疗的良性前列腺增生患者。
  • 未观察到术后尿路感染、吻合口漏、重大术后并发症、再入院或死亡;45例(93.7%)24小时内早期下床活动,术后住院中位时间2天。

关键数值与推荐

  • 成功即刻拔除尿管定义为术后自行排尿且无需再置管。
  • 路径失败定义为术后72小时内临床显著尿潴留需临时再置管。

临床怎么用

  • 在结构化围术期路径(含围术期坦索罗辛)下,可考虑机器人TME拔管前即刻拔除尿管。
  • 对原有良性前列腺增生并长期药物治疗者,术后排尿管理需个体化评估。

局限性

  • 单中心服务评估队列,非对照设计,不能证明优于传统尿管管理。
  • 样本量48例,再置管事件仅2例,精确95%CI较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative urinary retention remains an important concern following total mesorectal excision (TME), resulting in relatively conservative urinary catheter management despite advances in robotic surgery and enhanced recovery after surgery (ERAS) pathways. We evaluated the feasibility of immediate urinary catheter removal before extubation within a structured integrated perioperative pathway incorporating perioperative tamsulosin. METHODS: A prospective single-centre service evaluation cohort study was conducted between October 2024 and October 2025. Forty-eight consecutive patients undergoing robotic TME for rectal cancer were managed according to a predefined integrated perioperative pathway. All procedures were performed using the da Vinci Xi robotic platform. Tamsulosin 0.4 mg once daily was administered for three days before surgery and three postoperative days. Urinary catheters were removed immediately before extubation. The primary endpoint was successful immediate urinary catheter removal before extubation without the subsequent need for postoperative urinary recatheterisation. Successful immediate urinary catheter removal was defined as spontaneous postoperative voiding without the need for urinary recatheterisation. Failure of the pathway was defined as clinically significant postoperative urinary retention requiring temporary urinary recatheterisation within 72 h after surgery. Secondary outcomes included urinary tract infection, major postoperative morbidity, early mobilisation, readmission and length of stay. RESULTS: Mean age was 61 years and 31 patients (64.6%) were male. Thirty-eight patients (80%) received neoadjuvant treatment, 33 (68.8%) underwent surgery for ultra-low rectal cancer and 40 (83.3%) received a protective ileostomy. Successful immediate urinary catheter removal before extubation without postoperative urinary recatheterisation was achieved in 46 of 48 patients (95.8%). Two patients (4.2%) required temporary urinary recatheterisation because of clinically significant postoperative urinary retention. Recatheterisation occurred in two patients (4.2%; exact 95% confidence interval 0.5-14.3%), both with longstanding benign prostatic hyperplasia receiving chronic medical therapy. No postoperative urinary tract infections, anastomotic leaks, major postoperative complications, readmissions or mortality were observed. Early mobilisation within 24 h was achieved in 45 patients (93.7%), and median postoperative hospital stay was two days. CONCLUSION: Immediate urinary catheter removal before extubation was feasible in this prospective service evaluation cohort managed within a predefined integrated perioperative pathway. These findings support further prospective comparative evaluation but should not be interpreted as evidence of superiority over conventional catheter management. The concentration of recatheterisation events amongst patients with pre-existing benign prostatic hyperplasia supports further investigation of individualised postoperative urinary management.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Andriopoulou E, Anyfanti K, Petropoulou T, et al. Early removal of urinary catheter before extubation in robotic total mesorectal excision with perioperative tamsulosin. Surg Endosc. 2026. PMID: 42758176. doi:10.1007/s00464-026-13281-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。